Mealey's (March 30, 2020, 1:41 PM EDT) -- WASHINGTON, D.C. — In a March 25 appellee brief, the two named inventors of a patented treatment for castration resistant prostate cancer defend the rejection by a California federal judge of an appellant’s assertion that he is a co-inventor (Degui Chen v. Michael Jung, et al., No. 20-1255, Fed. Cir.)....